Ebola Outbreak in DRC Claims Over 3,000 Lives
Translated from Arabic, summarized and contextualized by DistantNews.
At a glance
- Ebola has caused over 3,000 infections and 1,354 deaths in the Democratic Republic of Congo since the outbreak began.
- The current outbreak, the 17th in the DRC, is concentrated in the eastern Ituri province, which borders South Sudan and Uganda.
- Health experts and organizations are working to develop vaccines and treatments for the circulating Bondibugyo strain of Ebola, with an experimental vaccine trial underway.
Authorities in the Democratic Republic of Congo have reported over 3,000 cases of Ebola, including 1,354 fatalities, since the virus first emerged in the country. The ongoing epidemic is particularly affecting the eastern region, an area that has endured over 30 years of armed conflict.
Ebola, a virus transmitted through close contact with bodily fluids, causes hemorrhagic fever and has claimed over 15,000 lives across Africa in the past 50 years. The most devastating outbreak in the DRC occurred between 2018 and 2020, resulting in approximately 2,300 deaths out of 3,500 reported cases.
The 17th outbreak of Ebola in the DRC was declared on May 15th. Currently, there is no vaccine or specific treatment available for the Bondibugyo strain prevalent in the country. As of July 15th, confirmed cases surpassed 2,000.
Data released by Congolese authorities on Sunday indicated 3,075 infections across five provinces, with 1,354 deaths. The report highlighted tangible improvements in case detection and confirmation, allowing for more precise monitoring of the situation. The epicenter of the epidemic is in Ituri province, bordering South Sudan and Uganda, where approximately 90% of cases are registered, according to the World Health Organization.
In recent days, several hospitals in the region have experienced strikes by staff demanding their salaries. Meanwhile, health experts and organizations are intensifying efforts to develop vaccines and treatments for the Bondibugyo strain. The first volunteer received an experimental vaccine for this Ebola strain last Friday, according to Oxford University. Work is accelerating on several other experimental vaccines, with clinical trials planned, alongside the development of two treatments.
Originally published by Hespress in Arabic. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.